{
  "id": "5fe31306a43ad3127800003c",
  "type": "summary",
  "question": "What is the chemical structure of Etanercept (ETN)?",
  "ideal_answer": "Etanercept (ETN) is a soluble fusion protein of the tumor necrosis factor receptor (TNFR) extracellular domain, linked to an Fc part of IgG1. It possesses three N- and 13 O-glycosylation sites, which form a complex with the plasma membrane protein Enbrel. Etanercept has been tested for treatment of solid cancers, including  glioblastoma and neuroblastoma, and liver fibrosis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29411222",
    "http://www.ncbi.nlm.nih.gov/pubmed/26665003",
    "http://www.ncbi.nlm.nih.gov/pubmed/24308717",
    "http://www.ncbi.nlm.nih.gov/pubmed/12510367",
    "http://www.ncbi.nlm.nih.gov/pubmed/23961669",
    "http://www.ncbi.nlm.nih.gov/pubmed/29020515",
    "http://www.ncbi.nlm.nih.gov/pubmed/24611432",
    "http://www.ncbi.nlm.nih.gov/pubmed/29887576",
    "http://www.ncbi.nlm.nih.gov/pubmed/28638112",
    "http://www.ncbi.nlm.nih.gov/pubmed/11336570"
  ],
  "snippets": [
    {
      "text": "Etanercept has the best retention rate in rheumatic diseases, but is less or not effective in granulomatous diseases, such as inflammatory bowel diseases or uveitis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24611432",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a highly glycosylated therapeutic Fc-fusion protein that contains multiple N- and O-glycosylation sites.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24308717",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a TNF\u03b1 receptor Fc fusion protein used for the treatment of rheumatic disease and psoriasis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28638112",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a soluble fusion protein of the tumor necrosis factor receptor (TNFR) extracellular domain, linked to an Fc part of IgG1. It possesses three N- and 13 O-glycosylation sites. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29411222",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a fusion protein, composed of the Fc portion of IgG1 and the extracellular domain of the TNF receptor (p75)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336570",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a dimeric genetic recombinant glycoprotein consisting of Fc domain of human Immunoglobulin G1 and the extracellular domain of human tumor necrosis factor (TNF) receptor type II",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29887576",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept (ETN) is a fusion protein of the receptor (CD120b) for tumor necrosis factor (TNF) and the Fc portion of IgG1. A ph",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23961669",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept (ETN), a recombinant TNF receptor (p75)-Fc fusion protein, competitively inhibits TNF-\u03b1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26665003",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept (ETN) is a fusion protein of the receptor (CD120b) for tumor necrosis factor (TNF) and the Fc portion of IgG1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23961669",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ETN is synthesized in Chinese hamster ovary cells by recombinant DNA technology as a fusion protein, with a fully human TNFRII ectodomain linked to the Fc portion of human IgG1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29020515",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a dimeric genetic recombinant glycoprotein consisting of Fc domain of human Immunoglobulin G1 and the extracellular domain of human tumor necrosis factor (TNF) receptor type II.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29887576",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a fusion protein, composed of the Fc portion of IgG1 and the extracellular domain of the TNF receptor (p75).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336570",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a protein comprised of the extracellular domains of two TNF receptors attached to a Fc portion of an IgG.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12510367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Etanercept is a soluble fusion protein of the tumor necrosis factor receptor (TNFR) extracellular domain, linked to an Fc part of IgG1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29411222",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}